Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Blue Haven RX vs LillyDirect Foundayo

Blue Haven RX
Graded #489

Lower grade

vs+16.400000000000006
LillyDirect Foundayo
Graded #173

Higher grade

The verdict

LillyDirect Foundayo takes it — 67.2/100 to 50.8/100.

LillyDirect Foundayo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLillyDirect Foundayo +27
45
72
Dose & formulationLillyDirect Foundayo +19
40
59
Clinical oversightLillyDirect Foundayo +9
69
78
Labs & monitoringLillyDirect Foundayo +1
51
52
FulfillmentLillyDirect Foundayo +9
71
80
Contract termsLillyDirect Foundayo +35
20
55
Blue Haven RX · left barLillyDirect Foundayo · right bar

The numbers

MetricBlue Haven RXLillyDirect Foundayo
WeighScore50.8/10067.2/100
GradeCC
Scorecard rank#489#173
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Blue Haven RX

Graded #489 · C

Strengths

  • Flat all-inclusive pricing — consult, prescription, medication and free shipping
  • Not charged until a US-licensed physician approves your prescription
  • Named operating entity disclosed (Eternum Health LLC)
  • Both compounded semaglutide and tirzepatide listed as in-stock

Where it loses points

  • Mixed third-party reviews — Trustpilot complaints on customer service and dosing
  • Doesn't publish the states it serves or specific pharmacy partners
  • No clearly verifiable accreditation badge (e.g. LegitScript) on the site
  • Compounded semaglutide and tirzepatide only — no brand-name or oral options
LillyDirect Foundayo

Graded #173 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard